<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5DF5258-6FC1-4F92-928B-2E970FF914D4"><gtr:id>D5DF5258-6FC1-4F92-928B-2E970FF914D4</gtr:id><gtr:name>The University of Iowa</gtr:name><gtr:address><gtr:line1>203 Van Allen Hall</gtr:line1><gtr:line4>Iowa City</gtr:line4><gtr:line5>IA 52242-1479</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0E80DBC1-A928-4E7B-8553-F59869930C27"><gtr:id>0E80DBC1-A928-4E7B-8553-F59869930C27</gtr:id><gtr:name>Virginia Polytechnic Institute &amp; State U</gtr:name><gtr:address><gtr:line1>Virginia Polytechnic Inst &amp; State  Univ</gtr:line1><gtr:line4>Blacksburg</gtr:line4><gtr:line5>Virginia</gtr:line5><gtr:postCode>VA 24061</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>Cal Unit (Medical Faculty)</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5DF5258-6FC1-4F92-928B-2E970FF914D4"><gtr:id>D5DF5258-6FC1-4F92-928B-2E970FF914D4</gtr:id><gtr:name>The University of Iowa</gtr:name><gtr:address><gtr:line1>203 Van Allen Hall</gtr:line1><gtr:line4>Iowa City</gtr:line4><gtr:line5>IA 52242-1479</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0E80DBC1-A928-4E7B-8553-F59869930C27"><gtr:id>0E80DBC1-A928-4E7B-8553-F59869930C27</gtr:id><gtr:name>Virginia Polytechnic Institute &amp; State U</gtr:name><gtr:address><gtr:line1>Virginia Polytechnic Inst &amp; State  Univ</gtr:line1><gtr:line4>Blacksburg</gtr:line4><gtr:line5>Virginia</gtr:line5><gtr:postCode>VA 24061</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8DDA911C-CBC8-4BD1-8DE1-E7FC4D89C88C"><gtr:id>8DDA911C-CBC8-4BD1-8DE1-E7FC4D89C88C</gtr:id><gtr:firstName>Alasdair</gtr:firstName><gtr:surname>MacKenzie</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9FAD231C-DA2D-4CBD-A1F3-BF11E5203F4E"><gtr:id>9FAD231C-DA2D-4CBD-A1F3-BF11E5203F4E</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>McGuffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6B47BAA5-7C9D-4EBB-ABCA-948A351C7BC9"><gtr:id>6B47BAA5-7C9D-4EBB-ABCA-948A351C7BC9</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Quinn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/834BE94F-BC05-4996-8A50-403EA71E549A"><gtr:id>834BE94F-BC05-4996-8A50-403EA71E549A</gtr:id><gtr:firstName>Gerome</gtr:firstName><gtr:otherNames>Daniel</gtr:otherNames><gtr:surname>Breen</gtr:surname><gtr:orcidId>0000-0003-2053-1792</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701003"><gtr:id>CB907E9B-A076-4F46-9AB1-75C335441B5B</gtr:id><gtr:title>Prediction and analysis of a regulatory SNP map of Major Depressive Disorder</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701003</gtr:grantReference><gtr:abstractText>Major depressive disorder (MDD) constitutes the most frequently occurring mental health problem in the world and will affect up to 25% of us during our lifetimes. Worryingly, MDD is on the increase. 
 This study will set out to find the genetic causes of MDD by examining changes in the DNA sequence of people who are more susceptible to depression. In addition, this study will determine why certain MDD sufferers do not respond to current treatments.
Previous studies of this type have examined possible changes in the regions the genome that make protein. 
Recently, however, it has been demonstrated that the majority of differences between individuals, including disease susceptibility, may be caused by changes, not in the genes themselves, but in the poorly understood DNA sequences that act as switches for these genes. These switches ensure that genes essential to healthy brain function are only used in the correct parts of the brain at the proper times and in the right dose. 
Unlike genes, little is known of these switches as, up to now they have been very hard to find. However, teams led by Dr. MacKenzie have had considerable success in identifying switches responsible for driving the expression of genes known to be involved in depression, addiction and inflammatory pain.
This project will combine Dr. Mackenzies ability to detect important switch sequences, that make up less than 5% of the genome, with our new ability to detect harmful mutations within these switches. Professor McGuffin and Dr. Breen will then analyse the DNA of over 1000 individuals suffering MDD to determine whether the occurrence of particular switch differences can be associated with susceptibility to MDD. Dr MacKenzie and Prof. Quinn will then carry out molecular biological studies of these switch differences to determine the biochemical pathways affected. In addition, Prof Quinn will evaluate how the activity of variants of these switches are affected by a number of known antidepressant drugs to determine the genetic causes of variation in MDD drug treatments.
By combining a number of newly developed computer based, patent sample based and molecular biology techniques this study has the real potential of hugely expanding our understanding of the mechanisms regulating the use of key genes in the brain and how changes on these mechanisms may contribute to susceptibility to MDD. Furthermore, this study will allow us to examine why many MDD sufferers do not respond to current anti-depressive medications.</gtr:abstractText><gtr:technicalSummary>Major Depressive Disorders (MDD) make up the most prevalent class of psychiatric disorders and will affect ~25% of us. The social and economic costs of these disorders are enormous with an estimated loss to the UK economy alone of some #9 billion per year. An additional problem facing the treatment of sufferers is variability in the efficacy of the drugs used to treat MDD.
These disorders have a strong genetic basis. Although many of these studies are still ongoing it is becoming clear that studying the effects of polymorphisms on coding regions alone will not give us a complete picture of the underlying causes. 
We will explore the hypothesis that susceptibility to MDD and variation in drug efficacy may also involve polymorphisms within the gene regulatory regions responsible for maintaining normal gene expression of components of systems including the serotoninergic, dopaminergic, tachykininergic, and NPY pathways. 
The objectives of this project will be to use a predictive systems biology approach to identify regulatory regions within the human genome by comparative genomics. The tissue specific and inducible status of these enhancer candidates will be analysed initially in primary cell lines and subsequently in transgenic animals in both the MacKenzie and Quinn labs. 
By concentrating on SNPs within highly conserved and thus functional regions of the genome this novel approach will greatly accelerate the association of SNPs within these regions with susceptibility to MDD that will be examined in large MDD patient samples in the Institute of Psychiatry by a team headed by McGuffin and Breen. 
Molecular analysis of protein-DNA interactions affected by these polymorphic ECRs will also be examined using a combination of EMSA and ChIP assay in the MacKenzie and Quinn labs. Finally, translational pharmacogenomic studies of the affects of a number of different psychoactive compounds on positively associated regulatory polymorphisms will be further examined using primary culture and in transgenic animals in the Quinn lab. 
This is a novel, ambitious and multi-disciplined approach involving a unique collaboration between 3 laboratories that are individually recognised as being international leaders in their respective fields. By applying a unique combination of systems biology, patient based association study and translational pharmacogenomics this exciting collaboration has the potential of changing our understanding of the causes of MDD and will act as a translational platform that will allow for the development of more effective and specific anti-depressive therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1007489</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Biotechnology Information (NCBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Shared Studentship</gtr:description><gtr:id>EACDE663-48C3-43D9-BF61-82B87D81B844</gtr:id><gtr:impact>We have a shared WT/NIH PhD student which is addressing DNA structure in areas of regulatory domains relevant for transcription</gtr:impact><gtr:outcomeId>hni3Y6vbWiJ-1</gtr:outcomeId><gtr:partnerContribution>We have a shared WT/NIH PhD student which is addressing DNA structure in areas of regulatory domains relevant for transcription</gtr:partnerContribution><gtr:piContribution>We have a shared WT/NIH PhD student which is addressing DNA structure in areas of regulatory domains relevant for transcription</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Tech</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Virginia Bioinformatics Institute</gtr:department><gtr:description>Bioinformatic analysis, Virginia Tech</gtr:description><gtr:id>63F5FB3D-3C00-470B-95C5-A52035CF2646</gtr:id><gtr:impact>Functional analysis of genetic analysis defining important genetic variants associated with neuroscience and cancer.</gtr:impact><gtr:outcomeId>XvhsDScCXew-1</gtr:outcomeId><gtr:partnerContribution>New skills set</gtr:partnerContribution><gtr:piContribution>Harold Skip Garner, Director of Virignia Tech Bioinformatic Institute</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Rowett Institute of Nutrition and Health Aberdeen</gtr:department><gtr:description>Regulation of hypothalamic galanin expression</gtr:description><gtr:id>64BB85B2-FDF8-4CAC-8DEA-894AAC0D2749</gtr:id><gtr:impact>We have used comparitive genomics to identify a gene regulatory region that supports expression of the galanin gene in the hypothalamus, amygdala and in sensory neurones. We have also found that this enhancer is highly polymorphic ans that polymorphisms affect the ability of the enhancer to activate transcription of a marker gene in primar hypothalamic neurones. We are in the process of completeing our studies and a paper has been published in the highly respected journal Neuropsychopharmocology</gtr:impact><gtr:outcomeId>E39B30BF24D-1</gtr:outcomeId><gtr:partnerContribution>Dr Perry Barrett brings expertise in hypothalamic function and in-situ hybridisation</gtr:partnerContribution><gtr:piContribution>A collaboration to understand the systems that regulate the expression of Galanin in the PVN of the hypothalamus and the amygdala.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Iowa</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Molecular Physiology and Biophysics</gtr:department><gtr:description>Regulation of the CGRP gene</gtr:description><gtr:id>A75384FA-6A56-4418-AA3B-4EA1A62B8ADA</gtr:id><gtr:impact>A manuscript is currently in preperation.</gtr:impact><gtr:outcomeId>GDsBrwLBUUv-1</gtr:outcomeId><gtr:partnerContribution>Working with Prof Russo we have identified and generated transgenic models with a novel CGRP enhancer region. The activity of this enhancer replicates many of the expression characteristics of the endogenous cgrp gene and overlaps the expression of Calcetonin in the thyroid gland. This work is currently in preperation for submision to PLOS one.</gtr:partnerContribution><gtr:piContribution>We made a transgenic line containing a reporter construct with the enhancer region previously identified and studied in the Russo lab. We also carried out immunohistochemical co-localisation between the activity of this enhancer and expression of the endogenous gene.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Manchester</gtr:department><gtr:description>determining the mechanisms of BDNF enhancer polymorphisms on cognitive decline in the elderly.</gtr:description><gtr:id>1CD90B38-57AA-4FBD-A494-F5A926E69148</gtr:id><gtr:impact>A paper describing this research has been invited for resubmission by Biological Psychiatry</gtr:impact><gtr:outcomeId>Cs4ncmM7Brv-1</gtr:outcomeId><gtr:partnerContribution>The University of Manchester provided association data for a SNP within a BDNF enahancer element that was associated with cognitive decline in the elderly. We have now show that this SNP affects the ability of the enhancer to activate BDNF promoter 4 in primary hippocampal neurones depolarised by KCl. Considering the important role played by BDNF in hippocampal plasticity the mechanistic linking of a cognitive disorder linked SNP and cell depolarisation in the hippocampus is highly significant.</gtr:partnerContribution><gtr:piContribution>We carried out the bioinformatic analysis, cloning and reproduction of the associated alleles using site directed mutatgenesis. We cloned promoter 4 of the BDNF gene and showed that this promoter drove marker gene expression in the limbic system including the amygdala and the hippocampus. Using luciferease assays in primary hippocampal cultures we were able to show that the associated polymorphism could significantly reduce the ability of the enhancer in which it was contained to activate promoter 4 in hippocampal neurones following depolarisation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Engineering</gtr:department><gtr:description>Development of a novel Algorithm to define SNP effects on DNA binding sites</gtr:description><gtr:id>E351FD50-2E81-41E1-88C9-FDD5C99347CB</gtr:id><gtr:impact>We have one paper in press (BMC genomics) and one to be submitted very soon in BMC computational biology that describes the development of a novel web site that allows researchers to predict the effects of non-coding polymorphisms on the binding of transcription factors</gtr:impact><gtr:outcomeId>D9A875A7E37-1</gtr:outcomeId><gtr:partnerContribution>Dr Starkey has brought expertise in Computer software engineering.</gtr:partnerContribution><gtr:piContribution>We have provided intellectual input and have guided the project from the biological perspective.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited speaker to the Wellcome Trust, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>65DE4D45-3E81-4EFF-B180-53C847DE3AB9</gtr:id><gtr:impact>I was one of three invited speakers involved in presenting a Wellcome trust exhibition entitled &amp;quot;Gut Reactions&amp;quot; which aimed to inform the general public about research into the genetics of appetite. The occation generated a great deal of audience interest and many questions and was reported in the Observer.

The occation generated an article in the Observer and was also reported in a number of other newspapers.</gtr:impact><gtr:outcomeId>R1egpJBDeif</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit-Glasgow</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>11F4693C-DCC6-4101-8D47-2D7A76AAC45C</gtr:id><gtr:impact>I gave a presentation of the importance of gene regulation on disease and evolution.

I hope that I motivated the students to learn more about biology</gtr:impact><gtr:outcomeId>4B9233BC7C9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio programmes</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2B9FE54C-7073-43CD-85F4-3D5B7FE2AF8B</gtr:id><gtr:impact>Interviewed on BBC RADIO ABERDEEN - NORTH EAST NEWS, NORTHSOUND 2 - NEWS, BBC RADIO SCOTLAND - NEWSDRIVE (06.06.08)

Invites to take part in television programmes.</gtr:impact><gtr:outcomeId>022242DE5B5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newspaper articles</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>21C51F3C-4E9E-40C5-AB9D-1CF8E39FCE75</gtr:id><gtr:impact>Articles published in the following news papers; PRESS &amp;amp; JOURNAL, THE SCOTTISH SUN, DAILY RECORD, THE SCOTSMAN, DAILY RECORD, METRO SCOTLAND, ABERDEEN EVENING EXPRESS, THE SCOTSMAN, THE HERALD (10.06.08)

I was subsequently invited to contribute to several radio programmes.</gtr:impact><gtr:outcomeId>A4688217012</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gene regulation, SNPs and disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>28C3D53C-B794-4F9F-AE84-AD46BD996101</gtr:id><gtr:impact>Many interesting questions were asked and views shared

I hope to have stimulated young people in the audience to pursue science as a career</gtr:impact><gtr:outcomeId>r-8797789466.3790150cdae52c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RegSNP - Predicting Allele Specific Differences in Transcription Factor - DNA binding</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CDFF42CD-BB9F-4BE4-B022-7C5422FE9CC4</gtr:id><gtr:impact>This website permits non-expert in biotechnology to identify the transcription factor bindingsites most affected by specific SNPs. The website also displays LD data, information on disease data and whether a particular SNP is GWAS associated or alters suceptibility to epigenetic modifiation.

Our web site has informed the research of many other researchers.</gtr:impact><gtr:outcomeId>r-6129737567.2773810cd8c350</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://viis.abdn.ac.uk/regsnp/Home.aspx</gtr:url><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gene regulatory variation in health and disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>77610308-F162-426A-97B5-CA2D877B2376</gtr:id><gtr:impact>Seminar/workshop

The talk stimulated a great deal of interest from the audience</gtr:impact><gtr:outcomeId>r-2983174410.63297370cdadf96</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at the Bradford Science festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F38218E5-636A-43CC-AE4A-258C1677FA02</gtr:id><gtr:impact>Over 40 reporters from all of the main newspapers and a number of science based magasines were present. This resulted in the production of a number of blogs, newspaper articles in papers such as the Guardian and articles in a number of magazines.

The publication of the work sparked a great deal of media interest.</gtr:impact><gtr:outcomeId>d95ZQKe8gMB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television appearances</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AB83723D-E7F1-49A8-801A-223E2BCA3F91</gtr:id><gtr:impact>Gave an interview about my work to BBC television.

Wider interest in my work.</gtr:impact><gtr:outcomeId>0712C32AD73</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GWA Studies, Gene Regulatory Variation and Disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>226D8FB6-97E2-4944-BA37-E71C2A8A8332</gtr:id><gtr:impact>Seminar/workshop

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-9525906312.7691920cdadb68</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>104000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Effects of stress, genetic and epigenetic variation on the control of the cannaboinnoid receptor gene; possible roles in disease and drug response stratification.</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Scotland</gtr:fundingOrg><gtr:id>248443F9-E428-404E-81F6-CDA7DF63B6A1</gtr:id><gtr:outcomeId>5ec931de5ec931f2</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>RegSNP is a new computer algorithm for the prediction of the effects of SNPs on transcription factor binding to DNA. The algorithm was released on line in the form of an easily usable web site.</gtr:description><gtr:id>92873436-4FC4-43E7-BD97-18023CF8E905</gtr:id><gtr:impact>The use of RegSNP allowed us to predict the effects of SNPs identified within the regulatory regions under study. We are also aware of the use of this web site by other researchers overseas.</gtr:impact><gtr:outcomeId>01F663FE6C1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RegSNP</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An antibody raised against the human BICC1 proteins</gtr:description><gtr:id>D88B61DB-2E30-4443-9EC2-61C8FAB3F139</gtr:id><gtr:impact>Detecting changes in the expression of the BICC1 protein will be critical to determining the mechanisms by which the BICC1 gene, that we have associated with major depressive disorder (MDD) using GWa studies, induces the symptoms of MDD. 
There are no commercial antibodies available against the human form Bicaudal C 1 homologue (BicC1). Two distinct antibodies raised in rabbit against the human homologue are being assessed for their potential to recognise the human form of BicC1 for future use in immunostaining and chromatin Immunoprecipitation assays. The human neuroblastoma cell lines used for assessing BicC1 ECR activity, SK-N-AS and SH SY5Y, were tested for the presence of BicC1 mRNA. A positive result in both cell lines suggested the presence of BicC1 in these cells lines. Furthermore, both the long isoform and the hypothetical short isoform were detected. Validation of the presence of BicC1 protein in these cell lines is now underway to confirm the existence of the BicC1 protein and to assess the antigenic potential of eight serum bleeds and four purified forms of the antibody that have been generated. Protein extracted from the neuroblastoma cell lines as well as that extracted from human embryonic kidney cells lines (HEK293), which should express BicC1 at high levels, is currently being used in western blot analysis. Initial results have shown a number of protein bands detected by both antibodies. One of these antibodies (recognising the epitope IKPKPKQPSKSVIVKSVER) would recognise both the long and the putative short isoform of BicC1. The purified from of this antibody gave a good signal with a band in the range of the expected size for the long form of BicC1. The second antibody that should only recognise the long isoform (recognising the epitope AAQGEPGYLAAQSDPGSNS), which gave poor ELISA results and was pooled from two sources, has failed to work in the purified form although serum bleeds of this antibody have identified a number of bands. Peptide competition of the antibody to determine specificity of the bands has thus far failed to compete bands although this is problematic for serum bleeds as antibody concentrations cannot be determined. For all antibodies generating bands one band in the kDa range for BicC1 appears consistently and this band is being prepared for identification by mass spectrophotometery using immunoprecipitation (IP) for enrichment.
The BicC1 antibodies are currently being used for IP in human neuroblastoma cell lines. These IP will be subsequently run on western blotting gels to isolate and enrich specific bands to be sent for mass spectrophotometery analysis at the proteomics facilities at the IOP, king's college, London.</gtr:impact><gtr:outcomeId>kZ9U2tJ6nCF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Rabbit anti human BICC1 antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>BicC1 over expression
A plasmid expressing a myc/DDK-tagged human BicC1 protein driven by a CMV promoter is being transfected into human neuroblastoma and HEK293 clonal lines. The mRNA message and protein expressed from this construct is being assessed by QPCR and western blotting, respectively, to determine the functionality of the construct. Western blotting is being performed with anti myc and anti DDK antibodies to confirm expression of the tagged protein. In addition, transfected cells are also being tested with the BicC1 antibodies to help boost the signal for optimising these antibodies. The tagged construct will allow determination of the localisation of the BicC1 protein within the cells. BicC1 has mostly been considered as an RNA binding protein and is chiefly located in the cytoplasm in other species. It is not yet been determined whether BicC1 can act as a DNA binding protein although it has KH domains similar to the hnRNPK single stranded nucleic acid binding protein which is a known regulator of DNA transcription. Localisation studies in combination with ChIP assays will go some way to determine whether BicC1 can act as a transcriptional regulator of gene expression in addition to its role in mRNA stability. Furthermore, changes in distribution of the BicC1 protein within the cellular environment will be assessed following specific challenges to the cells.</gtr:description><gtr:id>A5256D22-93EF-4418-B30C-56A98C28CA04</gtr:id><gtr:impact>Having a reliable source of BICC1 protein produced from mammalian cells will be vital to efforts to characterise the function and mechamism of this protein in disease</gtr:impact><gtr:outcomeId>Qzxc2z6xwNC</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BICC1 overexpressing cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic lines containing the BICC1 promoter driving expression of the LacZ marker gene.</gtr:description><gtr:id>03F8F8BC-04FC-43E7-9CB0-E76510228D5D</gtr:id><gtr:impact>Non-coding polymorphisms within the BICC1 gene have been associated with MDD. Nothing is known of the regulation of the BICC1 gene. Using comparitive genomics we identified and isolated the BICC1 gene promoter. This promoter was used to make reporter constructs which were then used to make transgenic mouse lines. These transgenic mouse lines expressed lacZ in many areas of the limbic system including the amygdala, hippocampus and cortex. By establishing the BICC1 promoter as being tissue specific we have established a platform for establishing the possible effects of non-coding SNPs in and around the BICC1 gene on the activity of its promoter in amygdala, hippocampal and cortical cells.</gtr:impact><gtr:outcomeId>VBPmZ1SbBkP</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BICC1 promoter transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Several transgenic lines werw generated using a plasmid containing the BDNF promoter 4 fused to the LacZ gene.</gtr:description><gtr:id>8C5C4ECE-42F6-49A2-894F-A131C889088A</gtr:id><gtr:impact>Non-coding polymorphisms within the BDNF gene have been associated with conditions as diverse as MDD, obesity and BD. In addition removal of BDNF promoter 4 has been shown to cause a reduction in cognition and memory in mice. However, Nothing is known of how many of the non-coding SNPs in and around the BDNF locus modulates the regulation of the BDNF gene. Using comparitive genomics we identified and isolated the BDNF gene promoter. This promoter was used to make reporter constructs which were then used to make transgenic mouse lines. These transgenic mouse lines expressed lacZ in many areas of the limbic system including the amygdala, hippocampus and cortex. By establishing the BDNF promoter-4 as being tissue specific we have established a platform for establishing the possible effects of non-coding SNPs in and around the BDNF gene on the activity of its promoter in amygdala, hippocampal and cortical cells.</gtr:impact><gtr:outcomeId>NtGrqpEDQie</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BDNF promoter 4 lacZ transgenic line.</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We optimized a novel method for the recovery, transfection and culture of primary neuonal cell lines derived from the amygdala, hypothalamus and hippocampus.</gtr:description><gtr:id>CBC65134-1FAA-4E35-BCBA-BD28F514E7C8</gtr:id><gtr:impact>The development of this technique removed much of the need to carry out experiments in whole animals.</gtr:impact><gtr:outcomeId>94AEACB6DA9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Magnetofection of primary neurones</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic lines produced by pro-nuclear microinjection</gtr:description><gtr:id>7FD73655-8997-482D-9184-42C7E4892DB1</gtr:id><gtr:impact>CACNA1c has been associated with bipolar disorder and schizophrenia by multiple GWAS analysis. By isolating and identifying the tissue specific properties of this promoter using transgenic analysis we have provided a platform for understanding the possible differential effects of non-coding SNPs on the expression of the CACNA1c gene in MDD.</gtr:impact><gtr:outcomeId>P5K3C81rdZP</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CACNA1c promoter transgenic line</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The MRC award allowed us to exapnd the capacity of our existing high performance computer (HPC) array. This has been of enormous benefit to our research effort and has profitted a number of other research groups around the University who require HPC array technology to carry out complex system biology type projects.</gtr:description><gtr:id>DD914B56-C1DA-47E3-9838-D2E3E2EDC0BD</gtr:id><gtr:impact>The provision of an expanded HPC systems has resulted in the publication of a manuscript in the high profile journal BMC genomics. We also hope to publish a number of other papers in BMC bioinformatics in the near future.</gtr:impact><gtr:outcomeId>8380D055601</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Expansion of the HPC array facility</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The material consists of a number of trangenic lines that contain reporter gene constructs made with enhancers identified during the time frame of the current projecty</gtr:description><gtr:id>09543015-7292-4F2A-8162-BF80FB1241AA</gtr:id><gtr:impact>The material provided allow for the assessment of the tissue specific and inducible properties of enhancers identified by comparitive genomics in vivo. These novel models allow for the production of persuasive in vivo data on the properties of novel enhancers. The regulatory regions currently being modelled in these lines include enhancers and promoters for Galanin, TAC1, CGRP, NPY, BDNF and CNR1.</gtr:impact><gtr:outcomeId>5D79F23D5C0</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Reporter gene transgenic lines</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CF3623D8-280B-4D23-8ADA-253A9F6EDEFF</gtr:id><gtr:title>Glucocorticoid receptor modulation of the TAC1 promoter in amygdala; polymorphisms, decoys stress and anxiety</gtr:title><gtr:parentPublicationTitle>10th congress of the European Neuropeptide Club, Gdynia, Poland</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d935f63f1217b13c7f0f79d9d7f96d68"><gtr:id>d935f63f1217b13c7f0f79d9d7f96d68</gtr:id><gtr:otherNames>MacKenzie</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>eoLvYAKwH4t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB739E30-2FDD-443A-80B8-57271351E52E</gtr:id><gtr:title>Stargazin involvement with bipolar disorder and response to lithium treatment.</gtr:title><gtr:parentPublicationTitle>Pharmacogenetics and genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fdc3a8b29c5f6984d04c65b7e7a6b93"><gtr:id>3fdc3a8b29c5f6984d04c65b7e7a6b93</gtr:id><gtr:otherNames>Silberberg G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-6872</gtr:issn><gtr:outcomeId>FD4024779CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2B8FBC7-F1DC-43E7-9210-7E22EA269292</gtr:id><gtr:title>Neuropeptides-2015, Aberdeen University, Scotland.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785e69a476c653925b46df6dbc09608c"><gtr:id>785e69a476c653925b46df6dbc09608c</gtr:id><gtr:otherNames>MacKenzie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>58b94ea8c19ba9.54011380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61DF1059-0E4F-4A01-9828-B41AA8093A65</gtr:id><gtr:title>Altered host response to murine gammaherpesvirus 68 infection in mice lacking the tachykinin 1 gene and the receptor for substance P.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/355a49fbb65c5f593b4d669c8c32a4f7"><gtr:id>355a49fbb65c5f593b4d669c8c32a4f7</gtr:id><gtr:otherNames>Quinn JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>ksR4eiK9S3i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26481095-F01A-48CC-8D41-AC4CB9C802D3</gtr:id><gtr:title>Genetic and environmental contributions to depression in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0442dc34d46c73b685681b286fc6ba38"><gtr:id>0442dc34d46c73b685681b286fc6ba38</gtr:id><gtr:otherNames>Ball HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>C21D33948CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A90509F6-5B5B-469E-8EA9-52C284AC376D</gtr:id><gtr:title>A genomewide linkage study on suicidality in major depressive disorder confirms evidence for linkage to 2p12.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ebd27033f64e4ed9e977b1c59a959fb"><gtr:id>7ebd27033f64e4ed9e977b1c59a959fb</gtr:id><gtr:otherNames>Butler AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>qE1Y3kT8Fc3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>399019A4-ADD6-476A-B7D3-121F07E9BB80</gtr:id><gtr:title>Induction of tachykinin production in airway epithelia in response to viral infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bd76766a55ab4003593a8e55f251200"><gtr:id>4bd76766a55ab4003593a8e55f251200</gtr:id><gtr:otherNames>Stewart JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>D2A64DA8757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3585921A-E18D-4A61-8ADE-124494F59308</gtr:id><gtr:title>Nitric oxide-NGF mediated PPTA/SP, ADNP, and VIP expression in the peripheral nervous system.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ecfa1fee6bee293505226ab7bdbcab0"><gtr:id>1ecfa1fee6bee293505226ab7bdbcab0</gtr:id><gtr:otherNames>Thippeswamy T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>6156C9F05DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B869EA8-7A87-4BB2-815A-410012B5DFD7</gtr:id><gtr:title>Identification and analysis of a highly conserved enhancer region within the CGRP locus</gtr:title><gtr:parentPublicationTitle>PLoS One</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94839fdae7d6eaf4551cf7edbefebf9d"><gtr:id>94839fdae7d6eaf4551cf7edbefebf9d</gtr:id><gtr:otherNames>Hing, Ben</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>AHNLCMEVnMP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C3450BF-DE3D-4FAD-9617-A8C0D213F0A5</gtr:id><gtr:title>Migraine in recurrent depression: case-control study.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51dbf807a74ad1441f5501539b2446bf"><gtr:id>51dbf807a74ad1441f5501539b2446bf</gtr:id><gtr:otherNames>Samaan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>58112C54A06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2F07C92-2799-4B09-97AD-1F62FAEFB8BE</gtr:id><gtr:title>Additive effect of BDNF and REST polymorphisms is associated with improved general cognitive ability.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/482d3b2888688e6d089b959ec62e3143"><gtr:id>482d3b2888688e6d089b959ec62e3143</gtr:id><gtr:otherNames>Miyajima F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>F234908DED8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8AB2855-7FA1-40EA-B636-8EBB9D8153FF</gtr:id><gtr:title>Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR.</gtr:title><gtr:parentPublicationTitle>Hormones &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d1a2b0a825a111a09e2bdc5a450a0cf"><gtr:id>7d1a2b0a825a111a09e2bdc5a450a0cf</gtr:id><gtr:otherNames>Hay CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1868-8497</gtr:issn><gtr:outcomeId>545a228dd6ec55.21975576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C0C41C0-42B1-4FAC-BEE3-BC9787009E94</gtr:id><gtr:title>Depression associated allelic variants within the BICC1 locus differentially regulate the BICC1 promoter in amygdala neurones.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8c499028baeb6a07cbb201d805e9aeb"><gtr:id>a8c499028baeb6a07cbb201d805e9aeb</gtr:id><gtr:otherNames>Davidson, Scott</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>gswcFBisE83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A17D6F3D-9E0A-4DED-A9CD-183ED41B9CDF</gtr:id><gtr:title>Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e06716f8e1a6a5996d09b885aae9cd2f"><gtr:id>e06716f8e1a6a5996d09b885aae9cd2f</gtr:id><gtr:otherNames>Psychiatric GWAS Consortium Bipolar Disorder Working Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>HgnxMnWmRJh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1535B34C-6066-402C-934C-1175D75263CE</gtr:id><gtr:title>Assessing the impact of genetic variation on transcriptional regulation in vitro.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa282898cbf0ed8a4679b0bacbd4824a"><gtr:id>aa282898cbf0ed8a4679b0bacbd4824a</gtr:id><gtr:otherNames>Ali FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>FeZfNBZLXnN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AF88540-4FB5-4F33-82A8-F8C2A8733FBD</gtr:id><gtr:title>An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895caa65c05270e6c177152078163120"><gtr:id>895caa65c05270e6c177152078163120</gtr:id><gtr:otherNames>Hay EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>58b94ea88f8c67.53904458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>695478E1-64C9-40BA-BF05-C1BB306090D5</gtr:id><gtr:title>Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurones.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3939ed816af20c9d27ff0042a1641a8"><gtr:id>a3939ed816af20c9d27ff0042a1641a8</gtr:id><gtr:otherNames>Shanley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>CX3xcdLeu9e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8875E3F8-FA63-4FCF-B92C-D584B83A979E</gtr:id><gtr:title>Twin study refining psychotic symptom dimensions as phenotypes for genetic research.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020bef27e8785ea89846c437a9488e4d"><gtr:id>020bef27e8785ea89846c437a9488e4d</gtr:id><gtr:otherNames>Cardno AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>D327288CB73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AAEDF56-85DD-4390-AAE4-F18BA436EDC5</gtr:id><gtr:title>Activity-dependent neuroprotective protein modulates its own gene expression.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd44aac1cc671be693cd1ad0470f3680"><gtr:id>cd44aac1cc671be693cd1ad0470f3680</gtr:id><gtr:otherNames>Aboonq MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>gYxvPCmHq2K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C01EA02C-0EEB-4D8A-8CF1-6113310C71F0</gtr:id><gtr:title>Exploring the effects of polymorphisms on cis-regulatory signal transduction response.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785e69a476c653925b46df6dbc09608c"><gtr:id>785e69a476c653925b46df6dbc09608c</gtr:id><gtr:otherNames>MacKenzie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>doi_53d00100193d0907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C173D9F0-04FD-44F6-A623-B8332C68F1D1</gtr:id><gtr:title>Production of yeast artificial chromosome transgenic mice by pronuclear injection of one-cell embryos.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785e69a476c653925b46df6dbc09608c"><gtr:id>785e69a476c653925b46df6dbc09608c</gtr:id><gtr:otherNames>MacKenzie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>8C5BA009140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74F54564-E87A-4EF5-89BC-E3403EC1F3BF</gtr:id><gtr:title>Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9767204d5910fc5b1fb0f80743d9379a"><gtr:id>9767204d5910fc5b1fb0f80743d9379a</gtr:id><gtr:otherNames>Uher R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>CfPvPkKq5Ps</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B492A764-EBF9-47A2-B762-265B48A19521</gtr:id><gtr:title>Genetics and delusional disorder.</gtr:title><gtr:parentPublicationTitle>Behavioral sciences &amp; the law</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020bef27e8785ea89846c437a9488e4d"><gtr:id>020bef27e8785ea89846c437a9488e4d</gtr:id><gtr:otherNames>Cardno AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0735-3936</gtr:issn><gtr:outcomeId>DB6BDE84AD9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0797043A-E227-4688-8CB2-B98969571DC1</gtr:id><gtr:title>Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e40f89bca597264e174cd864c70912df"><gtr:id>e40f89bca597264e174cd864c70912df</gtr:id><gtr:otherNames>Davidson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_5435a9d5a9df15bc3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B31CF8A6-7218-42FE-B83D-9AAD96A77B6B</gtr:id><gtr:title>A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3e7ec6c76109454dfda457a433a7d92"><gtr:id>f3e7ec6c76109454dfda457a433a7d92</gtr:id><gtr:otherNames>Guindalini C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>8F42E4FA48D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D68A8948-EA8C-4511-BFE9-52DDC2FF6A7F</gtr:id><gtr:title>Nitric oxide, a biological double-faced janus--is this good or bad?</gtr:title><gtr:parentPublicationTitle>Histology and histopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ecfa1fee6bee293505226ab7bdbcab0"><gtr:id>1ecfa1fee6bee293505226ab7bdbcab0</gtr:id><gtr:otherNames>Thippeswamy T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0213-3911</gtr:issn><gtr:outcomeId>DD579712A46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6D090A9-D5D0-450E-AD52-C6A3270F63BE</gtr:id><gtr:title>Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>YjsAFezy6Fa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9704497D-5027-4202-A316-8CBC1DC87D31</gtr:id><gtr:title>Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8c6e02867ac364f713bce4507271004"><gtr:id>d8c6e02867ac364f713bce4507271004</gtr:id><gtr:otherNames>Michelon L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>5906DB1BE92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74D9F176-A797-4886-B571-1D4CDE739AF5</gtr:id><gtr:title>Variable number tandem repeats as agents of functional regulation in the genome.</gtr:title><gtr:parentPublicationTitle>IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine &amp; Biology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b860966e744e7b358bf4b24c1965670d"><gtr:id>b860966e744e7b358bf4b24c1965670d</gtr:id><gtr:otherNames>Breen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0739-5175</gtr:issn><gtr:outcomeId>69E72FE36A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3E32B7B-016D-4797-8CED-AE44BDCBA804</gtr:id><gtr:title>The effects of nitric oxide inhibition prior to kainic acid treatment on neuro- and gliogenesis in the rat dentate gyrus in vivo and in vitro.</gtr:title><gtr:parentPublicationTitle>Histology and histopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5302a307aed97b5db695dbd0261bf4"><gtr:id>8b5302a307aed97b5db695dbd0261bf4</gtr:id><gtr:otherNames>Cosgrave AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0213-3911</gtr:issn><gtr:outcomeId>Zw3ytfJUnRi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>915818E4-4064-43B8-997B-709D158C4942</gtr:id><gtr:title>The relationship of maternal smoking to psychological problems in the offspring.</gtr:title><gtr:parentPublicationTitle>Early human development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f381a02d5274f271852d3c6651ea19e"><gtr:id>0f381a02d5274f271852d3c6651ea19e</gtr:id><gtr:otherNames>Button TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0378-3782</gtr:issn><gtr:outcomeId>1855B6737CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DDE8ECC-DA98-4EE5-8F06-95026FFBE4E1</gtr:id><gtr:title>Interspecies trait genetics reveals association of Adcy8 with mouse avoidance behavior and a human mood disorder.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c69b97d61f31b6fcc4d11ba2ae96906"><gtr:id>2c69b97d61f31b6fcc4d11ba2ae96906</gtr:id><gtr:otherNames>de Mooij-van Malsen AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>FE9377DE0F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A74C9C1F-D6D0-4044-B63B-BEEEDC2767D1</gtr:id><gtr:title>Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80ce7cf57cec916411895deb0fc884fa"><gtr:id>80ce7cf57cec916411895deb0fc884fa</gtr:id><gtr:otherNames>Ferreira MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>8BA52320012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>647933A2-7A4F-4C7B-9781-D39EA081EAE2</gtr:id><gtr:title>Determining Epigenetic Targets: A Beginner's Guide to Identifying Genome Functionality Through Database Analysis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895caa65c05270e6c177152078163120"><gtr:id>895caa65c05270e6c177152078163120</gtr:id><gtr:otherNames>Hay EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56d5b3bf8e4d48.54873941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8A9F78B-032D-4280-B173-C690F539A17B</gtr:id><gtr:title>Analysis of yeast artificial chromosome DNA by restriction digestion, southern blotting nucleic acid hybridization, and polymerase chain reaction.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3801296223dfc2978b3a2a95b2888ffa"><gtr:id>3801296223dfc2978b3a2a95b2888ffa</gtr:id><gtr:otherNames>Vasiliou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>B940F689362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B811808-7456-48CB-9EE1-255D09CBD6D6</gtr:id><gtr:title>Violence and post-traumatic stress disorder in Sao Paulo and Rio de Janeiro, Brazil: the protocol for an epidemiological and genetic survey.</gtr:title><gtr:parentPublicationTitle>BMC psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc7b10fffa5fccdacd5947d08fee0b34"><gtr:id>fc7b10fffa5fccdacd5947d08fee0b34</gtr:id><gtr:otherNames>Andreoli SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-244X</gtr:issn><gtr:outcomeId>5966CAE1C60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>222F65D1-6B4E-46A9-8613-8D8AA5E1E11A</gtr:id><gtr:title>Depression, migraine with aura and migraine without aura: their familiality and interrelatedness.</gtr:title><gtr:parentPublicationTitle>Cephalalgia : an international journal of headache</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0442dc34d46c73b685681b286fc6ba38"><gtr:id>0442dc34d46c73b685681b286fc6ba38</gtr:id><gtr:otherNames>Ball HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0333-1024</gtr:issn><gtr:outcomeId>EE9922DA435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5F4AA11-D6F6-45E2-8B9D-C31D9F680A2A</gtr:id><gtr:title>An evolutionary conserved region (ECR) in the human dopamine receptor D4 gene supports reporter gene expression in primary cultures derived from the rat cortex.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4551542d52b73b25e778c1c7a1085f7"><gtr:id>a4551542d52b73b25e778c1c7a1085f7</gtr:id><gtr:otherNames>Paredes UM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>KQduG1nXDKH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6811085-53A6-40EC-A709-402A2F05D3AF</gtr:id><gtr:title>Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.</gtr:title><gtr:parentPublicationTitle>The pharmacogenomics journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2251da90073003bf07924df6693465ca"><gtr:id>2251da90073003bf07924df6693465ca</gtr:id><gtr:otherNames>Perroud N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1470-269X</gtr:issn><gtr:outcomeId>CpNmNj9M7fe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45C7A4F1-AAD0-409E-924A-40951D1650FF</gtr:id><gtr:title>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>EEC0582E4C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C8715B4-C8C4-4719-A558-41B7779C09CB</gtr:id><gtr:title>The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>E333DA4FF55</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93C1DF9E-CAED-4094-9B42-25344C48DE72</gtr:id><gtr:title>Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neurones.</gtr:title><gtr:parentPublicationTitle>Neuro-Signals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3939ed816af20c9d27ff0042a1641a8"><gtr:id>a3939ed816af20c9d27ff0042a1641a8</gtr:id><gtr:otherNames>Shanley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1424-862X</gtr:issn><gtr:outcomeId>FE4yK9UMpPT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CD038B9-5596-4D48-9F01-5C9CB5752815</gtr:id><gtr:title>The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9767204d5910fc5b1fb0f80743d9379a"><gtr:id>9767204d5910fc5b1fb0f80743d9379a</gtr:id><gtr:otherNames>Uher R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>4AD50136E60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C75D67A7-F0EC-47B1-983F-383AB24BE58B</gtr:id><gtr:title>Understanding the Dynamics of Gene Regulatory Systems; Characterisation and Clinical Relevance of cis-Regulatory Polymorphisms.</gtr:title><gtr:parentPublicationTitle>Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a92dd29b1c6d0a7f2a231151843c0ea9"><gtr:id>a92dd29b1c6d0a7f2a231151843c0ea9</gtr:id><gtr:otherNames>Cowie P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2079-7737</gtr:issn><gtr:outcomeId>dXJkeFmkDyf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64BDFECE-CA44-489C-8F76-87E582464967</gtr:id><gtr:title>From age correction to genome-wide association.</gtr:title><gtr:parentPublicationTitle>Acta psychiatrica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e49081edc4813bed152b5addcf3dc7e"><gtr:id>0e49081edc4813bed152b5addcf3dc7e</gtr:id><gtr:otherNames>Cohen-Woods S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-690X</gtr:issn><gtr:outcomeId>A27EE68F5E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D422A18-073B-4788-8CBA-931B816FA37C</gtr:id><gtr:title>Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99a230ccbe492aea8059d5df8b033aba"><gtr:id>99a230ccbe492aea8059d5df8b033aba</gtr:id><gtr:otherNames>Roberts J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>BBD272B2274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C8646F-712F-43C6-913D-7949512D4FEF</gtr:id><gtr:title>Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c601a805f173a4991f1b619667ca44c2"><gtr:id>c601a805f173a4991f1b619667ca44c2</gtr:id><gtr:otherNames>Dehghan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>Sv3byvib9hR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5A1D030-F593-4C10-92EA-1D12A8F7E0A5</gtr:id><gtr:title>A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a04286f19143266b67092fed1b6acd3"><gtr:id>7a04286f19143266b67092fed1b6acd3</gtr:id><gtr:otherNames>Hing B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_15260_20_22265241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6686413A-F672-4107-AB98-F6D01DE280AF</gtr:id><gtr:title>History of suicide attempts among patients with depression in the GENDEP project.</gtr:title><gtr:parentPublicationTitle>Journal of affective disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2251da90073003bf07924df6693465ca"><gtr:id>2251da90073003bf07924df6693465ca</gtr:id><gtr:otherNames>Perroud N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-0327</gtr:issn><gtr:outcomeId>37D02D7AE0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08B2F812-2801-4199-B0A2-0CBE5F1869C4</gtr:id><gtr:title>Life after comparative genomics, regulatory systems, homeostasis, synergy, SNPs and disease.</gtr:title><gtr:parentPublicationTitle>Regulatory Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d935f63f1217b13c7f0f79d9d7f96d68"><gtr:id>d935f63f1217b13c7f0f79d9d7f96d68</gtr:id><gtr:otherNames>MacKenzie</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>tRUCfKANTA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A039A556-CA30-48BF-B5AE-F2364599CC82</gtr:id><gtr:title>Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db98fb67f0c9025c7bc35a474cb38d44"><gtr:id>db98fb67f0c9025c7bc35a474cb38d44</gtr:id><gtr:otherNames>Prata D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>4C1EEACE193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC9331F5-C26D-4279-B728-475A6364F747</gtr:id><gtr:title>Using functional annotation for the empirical determination of Bayes Factors for genome-wide association study analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf4169893a11ab3549158dd95501784"><gtr:id>ccf4169893a11ab3549158dd95501784</gtr:id><gtr:otherNames>Knight J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Y37nQRKJFCu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>864B5CD9-E952-4572-B109-E4BB61D2E73F</gtr:id><gtr:title>Epidemiology and symptomatology of depression in Sri Lanka: a cross-sectional population-based survey in Colombo District.</gtr:title><gtr:parentPublicationTitle>Journal of affective disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0442dc34d46c73b685681b286fc6ba38"><gtr:id>0442dc34d46c73b685681b286fc6ba38</gtr:id><gtr:otherNames>Ball HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-0327</gtr:issn><gtr:outcomeId>2DD8E281E91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C88DBB08-1255-4449-9517-0539CF92B1B3</gtr:id><gtr:title>Functional effects of polymorphisms on glucocorticoid receptor modulation of human anxiogenic substance-P gene promoter activity in primary amygdala neurones.</gtr:title><gtr:parentPublicationTitle>Psychoneuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d1a2b0a825a111a09e2bdc5a450a0cf"><gtr:id>7d1a2b0a825a111a09e2bdc5a450a0cf</gtr:id><gtr:otherNames>Hay CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0306-4530</gtr:issn><gtr:outcomeId>545a2365f126b7.10184618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E032E126-0A3B-404E-9C6B-4C806F8A6610</gtr:id><gtr:title>Evidence of uneven selective pressure on different subsets of the conserved human genome; implications for the significance of intronic and intergenic DNA.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e40f89bca597264e174cd864c70912df"><gtr:id>e40f89bca597264e174cd864c70912df</gtr:id><gtr:otherNames>Davidson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>1F67F0AD536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F43682F-CC59-4FF5-8C3D-08A7B3AA1275</gtr:id><gtr:title>Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c4d063186b91400d4ff66c798954ee"><gtr:id>40c4d063186b91400d4ff66c798954ee</gtr:id><gtr:otherNames>Schosser A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>25B4AC594CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8495516B-97B7-4BD0-A1C4-66AC75C65700</gtr:id><gtr:title>In utero exposure to cigarette smoke dysregulates human fetal ovarian developmental signalling.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0df40a07210bfd209d7add186c9e432"><gtr:id>d0df40a07210bfd209d7add186c9e432</gtr:id><gtr:otherNames>Fowler PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>545a23b2548dd1.79774776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5911E812-8D4A-4E36-A387-EA5A48FDE460</gtr:id><gtr:title>A remote and highly conserved enhancer supports amygdala specific expression of the gene encoding the anxiogenic neuropeptide substance-P.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e40f89bca597264e174cd864c70912df"><gtr:id>e40f89bca597264e174cd864c70912df</gtr:id><gtr:otherNames>Davidson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>ADD01939A32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99FABA99-44F6-4BE9-93BE-F8D7421CA85D</gtr:id><gtr:title>Response to the letter from Dr. Maher and colleagues re. Linkage on Suicidality.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ebd27033f64e4ed9e977b1c59a959fb"><gtr:id>7ebd27033f64e4ed9e977b1c59a959fb</gtr:id><gtr:otherNames>Butler AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>jgmZHsVL6cU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12D07131-700A-4496-9814-04F4101E71FC</gtr:id><gtr:title>The human neurokinin B gene, TAC3, and its promoter are regulated by Neuron Restrictive Silencing Factor (NRSF) transcription factor family.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54ffdd2a7200cf7ec2ccbf19f9907ee1"><gtr:id>54ffdd2a7200cf7ec2ccbf19f9907ee1</gtr:id><gtr:otherNames>Gillies S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>DBBBE23F18A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80490B0C-A686-43FC-A08E-811420050076</gtr:id><gtr:title>Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24cb7f731095a31e2c22e0c0cf02dbaf"><gtr:id>24cb7f731095a31e2c22e0c0cf02dbaf</gtr:id><gtr:otherNames>Gillies SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>bTyJoHqeteX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F58C5DA-FB9D-441C-B17A-1E12FF85D1C8</gtr:id><gtr:title>An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3aea45aefbb5dda8a32e10fc640870c"><gtr:id>e3aea45aefbb5dda8a32e10fc640870c</gtr:id><gtr:otherNames>Prata DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>170793215EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34536D36-7F9B-4B68-9CEB-F862139D4A6F</gtr:id><gtr:title>NRG1 gene in recurrent major depression: no association in a large-scale case-control association study.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c4d063186b91400d4ff66c798954ee"><gtr:id>40c4d063186b91400d4ff66c798954ee</gtr:id><gtr:otherNames>Schosser A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>9756F4EDC79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A13EDD79-E80F-41BD-B1D6-F94EB02AC1BC</gtr:id><gtr:title>Depressive disorder moderates the effect of the FTO gene on body mass index.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45685a8993b3af777327193ed1af1d0d"><gtr:id>45685a8993b3af777327193ed1af1d0d</gtr:id><gtr:otherNames>Rivera M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>gbopetEctp6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF23A226-6ECA-4ABA-8D3D-E54FFACB5C31</gtr:id><gtr:title>No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3'UTR of the DAT1 gene and adult attention deficit hyperactivity disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5881097c7a129f014aa1fdd0b0d271aa"><gtr:id>5881097c7a129f014aa1fdd0b0d271aa</gtr:id><gtr:otherNames>Br?ggemann D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>1183CE6D5F3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08F3F92F-E98E-40E5-87B7-81D6ABFE6290</gtr:id><gtr:title>Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14d9a362e28f67bc2f5870a25a0a3a0b"><gtr:id>14d9a362e28f67bc2f5870a25a0a3a0b</gtr:id><gtr:otherNames>Nicoll G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15260_20_22362764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0884973-B1A0-4046-B5B3-8CDFA345623B</gtr:id><gtr:title>Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e93a89334f9c50550bc48b84c0467cb"><gtr:id>7e93a89334f9c50550bc48b84c0467cb</gtr:id><gtr:otherNames>Richardson TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>545a245e6efee0.73257568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B43B9EA-3FBD-4E52-9DBA-F8DA113186A5</gtr:id><gtr:title>Intronic tandem repeat in the serotonin transporter gene in Old World monkeys: a new transcriptional regulator?</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4551542d52b73b25e778c1c7a1085f7"><gtr:id>a4551542d52b73b25e778c1c7a1085f7</gtr:id><gtr:otherNames>Paredes UM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>FWdG7NuFoLW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19AB99FC-3F61-4DE6-813A-AF17333D360B</gtr:id><gtr:title>Genomewide association scan of suicidal thoughts and behaviour in major depression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c4d063186b91400d4ff66c798954ee"><gtr:id>40c4d063186b91400d4ff66c798954ee</gtr:id><gtr:otherNames>Schosser A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>GECTNEKmAWF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E1DD721-32BB-4056-9D33-C43C7FFB3452</gtr:id><gtr:title>The neuronal transporter gene SLC6A15 confers risk to major depression.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f561bcf60738a6bd5763fce420cb8be9"><gtr:id>f561bcf60738a6bd5763fce420cb8be9</gtr:id><gtr:otherNames>Kohli MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>SoD8Pfh8AuT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CFED6C3-16DA-43B6-B1E8-E47331A18734</gtr:id><gtr:title>Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823c48973c29345516f9d1e7d9844cb"><gtr:id>7823c48973c29345516f9d1e7d9844cb</gtr:id><gtr:otherNames>Bilbao A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>0FBD2BF4A32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>070EA984-B250-419F-87C3-29CDEB0D3735</gtr:id><gtr:title>Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e49081edc4813bed152b5addcf3dc7e"><gtr:id>0e49081edc4813bed152b5addcf3dc7e</gtr:id><gtr:otherNames>Cohen-Woods S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>BAD2E3CA691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25B636DA-4D9C-408A-813E-8755A2A30BBA</gtr:id><gtr:title>The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9e43b467f4d3ca35c3c7d558a88adb5"><gtr:id>b9e43b467f4d3ca35c3c7d558a88adb5</gtr:id><gtr:otherNames>Green EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>23DA0CBDCB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20340EF4-A92B-4E05-96C8-4D50B69BB546</gtr:id><gtr:title>Does cholesterol drive atherosclerosis?</gtr:title><gtr:parentPublicationTitle>Translational Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2514ad85efb88fc5b44a6f8312f6783d"><gtr:id>2514ad85efb88fc5b44a6f8312f6783d</gtr:id><gtr:otherNames>R. Ware W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>P2zxUNNR6NV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5A1EC9E-5747-42DA-A206-8C25443F84C0</gtr:id><gtr:title>Twin study of illness history variables in psychosis.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d0703425eafa2156307a6091dd47471"><gtr:id>3d0703425eafa2156307a6091dd47471</gtr:id><gtr:otherNames>Allan CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>0FE80BB894C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0682526-7FD1-46FD-B6F6-8150235B4F37</gtr:id><gtr:title>Expression of the human PAC1 receptor leads to dose-dependent hydrocephalus-related abnormalities in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa92ea8d8f59bb90370c87f200cdd925"><gtr:id>aa92ea8d8f59bb90370c87f200cdd925</gtr:id><gtr:otherNames>Lang B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>F436E9E20BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8CF430E-2977-4D53-AF74-7BCA541ACDB8</gtr:id><gtr:title>Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10a0f123d6d0503d92e86200881c0b4a"><gtr:id>10a0f123d6d0503d92e86200881c0b4a</gtr:id><gtr:otherNames>Karwautz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>DFFB475BDCE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F99F660-567F-434B-9EAC-5C784A24D910</gtr:id><gtr:title>Disease associated polymorphisms and epigenetics differentially regulate the promoter of the cannabinnoid receptor gene in primary neurones</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60bbae51d4be1f4e38b3af5d39d28e87"><gtr:id>60bbae51d4be1f4e38b3af5d39d28e87</gtr:id><gtr:otherNames>Cowie</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>fyp9Cmcogxw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1C4F52D-6AD8-48C1-86FC-2C3278325D9A</gtr:id><gtr:title>Can recreational doses of THC produce significant dopamine release in the human striatum?</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ef610bf70a2414f028fadc10f8091b2"><gtr:id>9ef610bf70a2414f028fadc10f8091b2</gtr:id><gtr:otherNames>Stokes PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>EB8CF7F285D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E5B3A90-B9F9-4E85-895C-24524F044A1C</gtr:id><gtr:title>A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6b0ceb667456e73b24a2e4246c56b4a"><gtr:id>a6b0ceb667456e73b24a2e4246c56b4a</gtr:id><gtr:otherNames>de Sousa SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>A6348BF7FF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28E6626B-63C0-48C4-A794-AEABE9A49239</gtr:id><gtr:title>Mechanical stimulation induces preprotachykinin gene expression in osteoarthritic chondrocytes which is correlated with modulation of the transcription factor neuron restrictive silence factor.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07ca4167166ca05bf960b62973a5a75"><gtr:id>b07ca4167166ca05bf960b62973a5a75</gtr:id><gtr:otherNames>Howard MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>ACBAF5203DA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6936C848-7CC5-49AB-A5A2-A7AA2298A9D1</gtr:id><gtr:title>The SLC6A4 VNTR genotype determines transcription factor binding and epigenetic variation of this gene in response to cocaine in vitro.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25881597e12a2ccee8ef5479f80775c9"><gtr:id>25881597e12a2ccee8ef5479f80775c9</gtr:id><gtr:otherNames>Vasiliou SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>dCfmwzoCFis</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2568197-7D2E-4D3E-A942-64968A35B7F0</gtr:id><gtr:title>Moderation of antidepressant response by the serotonin transporter gene.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b941a77bdfc8fd1e9f7b548a09ff635a"><gtr:id>b941a77bdfc8fd1e9f7b548a09ff635a</gtr:id><gtr:otherNames>Huezo-Diaz P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>75A1C821300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D5A9FC-647D-4CC3-A055-0920B0CBD530</gtr:id><gtr:title>A regulatory domain spanning the repeat sequence RE1 from herpes simplex virus type 1 has cell specific differential functions in trigeminal neurons and fibroblasts.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e412bde39c575196ce313afbd207ae0"><gtr:id>0e412bde39c575196ce313afbd207ae0</gtr:id><gtr:otherNames>Stevens HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>2F7EFE9D5C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A66902E-ED39-44B3-A9AB-7374CD7147A0</gtr:id><gtr:title>Exploring the impact of regulatory polymorphisms on drug response and disease; the future of stratified and personalized medicine?</gtr:title><gtr:parentPublicationTitle>16th international symposium on Molecular Medicine, Crete, Greece.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29d5762deb1145c97caa4fff2fde71a3"><gtr:id>29d5762deb1145c97caa4fff2fde71a3</gtr:id><gtr:otherNames>MacKenzie, Alasdair</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>ew55urNdFGi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB337DEF-1FAA-45A2-9C80-1743EB25A3E4</gtr:id><gtr:title>Genome-wide association analysis of copy number variation in recurrent depressive disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ad69d0075e0c62d4b08466ea94c563"><gtr:id>55ad69d0075e0c62d4b08466ea94c563</gtr:id><gtr:otherNames>Rucker JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>V6DpvuvxEnm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A9D4759-63D1-41FF-BBA8-112EBE220E74</gtr:id><gtr:title>Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b2aaf1b7109ac42d9d9d55641e4ae7f"><gtr:id>3b2aaf1b7109ac42d9d9d55641e4ae7f</gtr:id><gtr:otherNames>Hamshere ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>A4EF26E02D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E14A95D-D088-418B-B4EC-0852B1D142CF</gtr:id><gtr:title>A genome-wide significant linkage for severe depression on chromosome 3: the depression network study.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b860966e744e7b358bf4b24c1965670d"><gtr:id>b860966e744e7b358bf4b24c1965670d</gtr:id><gtr:otherNames>Breen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>VWJ8h5UZYyn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C57D2EE-EE56-40F1-973F-955BFCBB7090</gtr:id><gtr:title>Investigation of Van Gogh-like 2 mRNA regulation and localisation in response to nociception in the brain of adult common carp (Cyprinus carpio).</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deff182221a9bea92240008f4e1e1be8"><gtr:id>deff182221a9bea92240008f4e1e1be8</gtr:id><gtr:otherNames>Reilly SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>6425C1917BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64384096-2F67-4B43-8ED7-0571A096F0F4</gtr:id><gtr:title>Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2251da90073003bf07924df6693465ca"><gtr:id>2251da90073003bf07924df6693465ca</gtr:id><gtr:otherNames>Perroud N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>1397B35D7FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA538653-15A8-476B-9304-CD4B349DA12B</gtr:id><gtr:title>Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3aea45aefbb5dda8a32e10fc640870c"><gtr:id>e3aea45aefbb5dda8a32e10fc640870c</gtr:id><gtr:otherNames>Prata DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>D88E79AB56A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A067E195-505E-407D-9CC9-E45E734FBE5B</gtr:id><gtr:title>Genome-wide association study of major recurrent depression in the U.K. population.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6dccf135b9a077b6dca4f42e6bcc8f5"><gtr:id>a6dccf135b9a077b6dca4f42e6bcc8f5</gtr:id><gtr:otherNames>Lewis CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>pm_5435a9e5a9e185140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D40C7FB-49B7-4B6A-A070-2C99E7D3F224</gtr:id><gtr:title>Evidence of postnatal neurogenesis in dorsal root ganglion: role of nitric oxide and neuronal restrictive silencer transcription factor.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a1fcddf99103d4d5702fb0ce2a3a4b3"><gtr:id>1a1fcddf99103d4d5702fb0ce2a3a4b3</gtr:id><gtr:otherNames>Arora DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>B1F339F8185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF2E0EA4-42D1-4E6F-BE5B-CA20AAD5313E</gtr:id><gtr:title>Nitric oxide regulates activity-dependent neuroprotective protein (ADNP) in the dentate gyrus of the rodent model of kainic acid-induced seizure.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5302a307aed97b5db695dbd0261bf4"><gtr:id>8b5302a307aed97b5db695dbd0261bf4</gtr:id><gtr:otherNames>Cosgrave AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>B7AEFB83315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B9FE8EA-3E25-474D-9356-94F8E8A8FCD7</gtr:id><gtr:title>Clinical characteristics of unipolar disorder and bipolar disorder according to the lifetime presence of recurrent panic attacks.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0bb8711f03095ed3fbb34c06f218551"><gtr:id>c0bb8711f03095ed3fbb34c06f218551</gtr:id><gtr:otherNames>Forty L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>1F947C88692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F57CAC4-09D4-4574-8CCF-0AEBC940F8C8</gtr:id><gtr:title>No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad8bb1b1f46e86eb47f2af8323561110"><gtr:id>ad8bb1b1f46e86eb47f2af8323561110</gtr:id><gtr:otherNames>Gaysina D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>8E3D97A77B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>894B517C-F09E-4AED-A4D2-0C544EEAA055</gtr:id><gtr:title>Towards &amp;quot;systems psychiatry&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b860966e744e7b358bf4b24c1965670d"><gtr:id>b860966e744e7b358bf4b24c1965670d</gtr:id><gtr:otherNames>Breen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1516-4446</gtr:issn><gtr:outcomeId>4DEC710FE06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31E3EB6D-6A2A-4783-AAA6-837FB1DF2114</gtr:id><gtr:title>Molecular genetics of monoamine transporters: relevance to brain disorders.</gtr:title><gtr:parentPublicationTitle>Neurochemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58b6cb074850c1cfcbdc78a994cd6228"><gtr:id>58b6cb074850c1cfcbdc78a994cd6228</gtr:id><gtr:otherNames>Haddley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-3190</gtr:issn><gtr:outcomeId>1247E21C163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4A1DFDF-7F3F-4854-B70F-FF9C885747C9</gtr:id><gtr:title>Association analysis of GRK3 gene promoter variants in cocaine abuse.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3e7ec6c76109454dfda457a433a7d92"><gtr:id>f3e7ec6c76109454dfda457a433a7d92</gtr:id><gtr:otherNames>Guindalini C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>93BB49F4282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3992AFB6-C5E3-4AD9-ABB5-4D6B961DFDAE</gtr:id><gtr:title>Trajectories of change in depression severity during treatment with antidepressants.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9767204d5910fc5b1fb0f80743d9379a"><gtr:id>9767204d5910fc5b1fb0f80743d9379a</gtr:id><gtr:otherNames>Uher R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>649BA2283EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBDE1464-9D2C-49FB-9DB9-E878992B59BE</gtr:id><gtr:title>MDD associated SNPs within the BICC1 gene differentially regulate the activity of the BICC1 promoter in amygdala;</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed0260af2b632e6698160a9ffe8286e"><gtr:id>5ed0260af2b632e6698160a9ffe8286e</gtr:id><gtr:otherNames>Scott Davidson</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>LB1zhNn9kVm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D543BE84-85F9-460B-BF19-4288B1563B5C</gtr:id><gtr:title>Using the CRISPR/Cas9 system to understand neuropeptide biology and regulation.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895caa65c05270e6c177152078163120"><gtr:id>895caa65c05270e6c177152078163120</gtr:id><gtr:otherNames>Hay EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>58b94ea82ad598.37400082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE3297F8-D74F-45EA-B391-466DDD186582</gtr:id><gtr:title>Lithium chloride regulation of the substance P encoding preprotachykinin a, Tac1 gene in rat hippocampal primary cells.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58b6cb074850c1cfcbdc78a994cd6228"><gtr:id>58b6cb074850c1cfcbdc78a994cd6228</gtr:id><gtr:otherNames>Haddley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>Pdsn12EMK2U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DF1160A-B856-4434-8DB7-B95F12BB8E4C</gtr:id><gtr:title>Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment.</gtr:title><gtr:parentPublicationTitle>Pharmacogenetics and genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c39b943c3d26152f77baeda36edca854"><gtr:id>c39b943c3d26152f77baeda36edca854</gtr:id><gtr:otherNames>O'Gara C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-6872</gtr:issn><gtr:outcomeId>123FC719FF4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>087A611A-54B8-4371-B9E1-18F8E182CD97</gtr:id><gtr:title>Regulation of activity-dependent neuroprotective protein (ADNP) by the NO-cGMP pathway in the hippocampus during kainic acid-induced seizure.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5302a307aed97b5db695dbd0261bf4"><gtr:id>8b5302a307aed97b5db695dbd0261bf4</gtr:id><gtr:otherNames>Cosgrave AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>2855A746976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ED2C214-8C72-4848-B185-49FF43B1C812</gtr:id><gtr:title>Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9767204d5910fc5b1fb0f80743d9379a"><gtr:id>9767204d5910fc5b1fb0f80743d9379a</gtr:id><gtr:otherNames>Uher R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>96A46D8E21F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FB0044E-3F00-4E84-9345-FAD5E1781B5D</gtr:id><gtr:title>An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d1a2b0a825a111a09e2bdc5a450a0cf"><gtr:id>7d1a2b0a825a111a09e2bdc5a450a0cf</gtr:id><gtr:otherNames>Hay CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d5b3bf6566a4.64978906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CF92416-4B52-40FA-A48E-E10466495BB2</gtr:id><gtr:title>The androgen receptor gene polyglycine repeat polymorphism is associated with memory performance in healthy Chinese individuals.</gtr:title><gtr:parentPublicationTitle>Psychoneuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc53662b8f8e7fb53836f8056ddd3c66"><gtr:id>cc53662b8f8e7fb53836f8056ddd3c66</gtr:id><gtr:otherNames>Kovacs D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0306-4530</gtr:issn><gtr:outcomeId>1C0383A8703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BA47EC9-AAC7-47DC-90FB-1B7255FBBB57</gtr:id><gtr:title>Dopamine-beta hydroxylase polymorphism and cocaine addiction.</gtr:title><gtr:parentPublicationTitle>Behavioral and brain functions : BBF</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3e7ec6c76109454dfda457a433a7d92"><gtr:id>f3e7ec6c76109454dfda457a433a7d92</gtr:id><gtr:otherNames>Guindalini C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-9081</gtr:issn><gtr:outcomeId>0CB1DA0F78B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65E7D583-DFE6-4461-87FD-9F4FCF719862</gtr:id><gtr:title>Prediction and characterisation of a highly conserved, remote and cAMP responsive enhancer that regulates Msx1 gene expression in cardiac neural crest and outflow tract.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd34123b174187726e41b36166f75723"><gtr:id>fd34123b174187726e41b36166f75723</gtr:id><gtr:otherNames>Miller KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>8EADD5B35EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8208048-1D05-418B-BDCF-3E756634F77E</gtr:id><gtr:title>A highly conserved Wnt-dependent TCF4 binding site within the proximal enhancer of the anti-myogenic Msx1 gene supports expression within Pax3-expressing limb bud muscle precursor cells.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd34123b174187726e41b36166f75723"><gtr:id>fd34123b174187726e41b36166f75723</gtr:id><gtr:otherNames>Miller KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>1637163592D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97FC012C-A04A-4FA5-A93F-420C7E8F3346</gtr:id><gtr:title>Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2251da90073003bf07924df6693465ca"><gtr:id>2251da90073003bf07924df6693465ca</gtr:id><gtr:otherNames>Perroud N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>14573535010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>889067A4-2096-4CF1-9D68-9470515D31FB</gtr:id><gtr:title>Genetic overlap between measures of hyperactivity/inattention and mood in children and adolescents.</gtr:title><gtr:parentPublicationTitle>Journal of the American Academy of Child and Adolescent Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb560abe76472c1dff34905682d0dbcd"><gtr:id>fb560abe76472c1dff34905682d0dbcd</gtr:id><gtr:otherNames>Cole J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0890-8567</gtr:issn><gtr:outcomeId>4DEF4C1A292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54B7AFCF-D550-48CB-AD80-3675E5E6675B</gtr:id><gtr:title>Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones.</gtr:title><gtr:parentPublicationTitle>The pharmacogenomics journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e40f89bca597264e174cd864c70912df"><gtr:id>e40f89bca597264e174cd864c70912df</gtr:id><gtr:otherNames>Davidson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-269X</gtr:issn><gtr:outcomeId>56d5b3bfb605d8.08927104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27188491-5975-4D01-9114-4EA7DE7C9C52</gtr:id><gtr:title>The effect of positive mood induction on emotional processing in euthymic individuals with bipolar disorder and controls.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/434b0d0bfe76b823d106fa758c7aaeff"><gtr:id>434b0d0bfe76b823d106fa758c7aaeff</gtr:id><gtr:otherNames>Roiser J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>FDFF4B012F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E272BC2F-2278-414A-B64F-4F5F6BD638D1</gtr:id><gtr:title>Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48199838cc2f29a1eac9e5f8f6b0422"><gtr:id>c48199838cc2f29a1eac9e5f8f6b0422</gtr:id><gtr:otherNames>Grozeva D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>HzziDmGTbZ6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>310CA7A6-38FD-4DED-B57C-AE612FEF8DD0</gtr:id><gtr:title>Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19b9db0b550b966f562706a2344b5366"><gtr:id>19b9db0b550b966f562706a2344b5366</gtr:id><gtr:otherNames>Spencer EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>BA47551A10A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F101A5C-EF30-4DEB-9386-10C9417AD4A8</gtr:id><gtr:title>Medical disorders in people with recurrent depression.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b2eac2fb9616749f5baa65271de9fd"><gtr:id>59b2eac2fb9616749f5baa65271de9fd</gtr:id><gtr:otherNames>Farmer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>BFCC839A678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4E22B7B-B8BF-47E2-8281-4B9FD4F412C5</gtr:id><gtr:title>Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d072cf87a99ce00cd3e7bd97d55cc320"><gtr:id>d072cf87a99ce00cd3e7bd97d55cc320</gtr:id><gtr:otherNames>Flomen RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>B30A8F9819B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C87ED288-101B-4CBE-8075-7A5A7C23711A</gtr:id><gtr:title>Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa282898cbf0ed8a4679b0bacbd4824a"><gtr:id>aa282898cbf0ed8a4679b0bacbd4824a</gtr:id><gtr:otherNames>Ali FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>A11C174C891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6800F8DB-E404-43DA-B765-D78AEBC834EF</gtr:id><gtr:title>Association of the dysbindin gene with bipolar affective disorder.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b860966e744e7b358bf4b24c1965670d"><gtr:id>b860966e744e7b358bf4b24c1965670d</gtr:id><gtr:otherNames>Breen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>5D5647AE051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>394B182C-A65F-47F5-942E-38EBEC57C32E</gtr:id><gtr:title>Modulation of orbitofrontal response to amphetamine by a functional variant of DAT1 and in vitro confirmation.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bb144198f201ee463f36ffc8c303511"><gtr:id>8bb144198f201ee463f36ffc8c303511</gtr:id><gtr:otherNames>Brotons O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>Kfqvcc9LTdA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>082F6B31-305F-40D7-8D0A-3C6326D82A3C</gtr:id><gtr:title>The posttraumatic stress disorder project in Brazil: neuropsychological, structural and molecular neuroimaging studies in victims of urban violence.</gtr:title><gtr:parentPublicationTitle>BMC psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d71230216fcd5fa601c78641df0213f"><gtr:id>1d71230216fcd5fa601c78641df0213f</gtr:id><gtr:otherNames>Bressan RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-244X</gtr:issn><gtr:outcomeId>D201F2C3647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>135BC546-3874-4441-A18F-BB8F844F0DF3</gtr:id><gtr:title>Postgenomic bioinformatic analysis of yeast artificial chromosome sequence.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/624b009b256ffe123149553422824fce"><gtr:id>624b009b256ffe123149553422824fce</gtr:id><gtr:otherNames>Miller K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>A73C432CEB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0421A12F-5EC4-42A5-AEAA-8EA699CA0AAE</gtr:id><gtr:title>A pilot study of positive mood induction in euthymic bipolar subjects compared with healthy controls.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b2eac2fb9616749f5baa65271de9fd"><gtr:id>59b2eac2fb9616749f5baa65271de9fd</gtr:id><gtr:otherNames>Farmer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>6A8D0456F80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F0768A9-3D4B-41F0-8418-1AC8469F1345</gtr:id><gtr:title>Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R).</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac3a50989f3144f18c0b6a7e5fcbc257"><gtr:id>ac3a50989f3144f18c0b6a7e5fcbc257</gtr:id><gtr:otherNames>Vasiliou AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>BC2A4919665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF23EA7C-4ECB-4C12-BC7F-095D2D5C7813</gtr:id><gtr:title>NO-cGMP mediated galanin expression in NGF-deprived or axotomized sensory neurons.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ecfa1fee6bee293505226ab7bdbcab0"><gtr:id>1ecfa1fee6bee293505226ab7bdbcab0</gtr:id><gtr:otherNames>Thippeswamy T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>7EEE809D7C5</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701003</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>